BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19091718)

  • 1. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Virgilio R; Corti S; Agazzi P; Santoro D; Lanfranconi S; Candelise L; Bresolin N; Comi GP; Bersano A
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):95-6. PubMed ID: 19091718
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
    Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
    Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy.
    Pedroso JL; Braga-Neto P; Dutra LA; Barsottini OG
    Arq Neuropsiquiatr; 2011 Dec; 69(6):993. PubMed ID: 22297896
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment.
    Nociti V; Frisullo G; Tartaglione T; Patanella AK; Iorio R; Tonali PA; Batocchi AP
    Eur J Neurol; 2010 Jan; 17(1):e5. PubMed ID: 19906270
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Rouco I; Hurtado P; Castaño L; Zarranz JJ
    Neurologia; 2015 May; 30(4):247-9. PubMed ID: 24075582
    [No Abstract]   [Full Text] [Related]  

  • 6. Excellent response to steroid treatment in anti-GAD cerebellar ataxia.
    Lauria G; Pareyson D; Pitzolu MG; Bazzigaluppi E
    Lancet Neurol; 2003 Oct; 2(10):634-5. PubMed ID: 14505586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.
    di Biase L; Assenza G; Iorio R; Melgari JM; Salomone G; Marano M; Muda AO; Di Lazzaro V
    Parkinsonism Relat Disord; 2016 Sep; 30():78-80. PubMed ID: 27236207
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmune cerebellar ataxia].
    Nanri K; Okuma M; Sato S; Taguchi T; Tanaka N
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():632-7. PubMed ID: 26480769
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebellar ataxia and nystagmus with GAD antibodies in a woman from the West Indies : a video demonstration.
    Ramcharan K; Reyes AJ; Abdool K; Raamkaransingh N
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31615777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
    Mitoma H; Nanri K
    Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Abele M; Weller M; Mescheriakov S; Bürk K; Dichgans J; Klockgether T
    Neurology; 1999 Mar; 52(4):857-9. PubMed ID: 10078741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report.
    Villa SM; Rufa A; Malandrini A; Cerase A; Rosini F; Arrigucci U; Federico A
    Neurol Sci; 2019 Jun; 40(6):1303-1306. PubMed ID: 30635801
    [No Abstract]   [Full Text] [Related]  

  • 17. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Planche V; Marques A; Ulla M; Ruivard M; Durif F
    Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune cerebellar ataxia with glutamic acid decarboxylase 65 antibodies associated with central vestibular symptoms.
    London F; Hadhoum N; Zéphir H; Outteryck O; Vermersch P
    Acta Neurol Belg; 2017 Sep; 117(3):775-776. PubMed ID: 27988832
    [No Abstract]   [Full Text] [Related]  

  • 20. Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase.
    Simon NG; Vucic S; Joffe R; Kiernan MC
    J Neurol; 2014 Jan; 261(1):238-9. PubMed ID: 24292643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.